✦ LIBER ✦

Phase I Trial of Sunitinib Malate plus Interferon-α for Patients with Metastatic Renal Cell Carcinoma

✍ Scribed by Robert J. Motzer; Gary Hudes; George Wilding; Lawrence H. Schwartz; Subramanian Hariharan; Susan Kempin; Rana Fayyad; Robert A. Figlin

Book ID: 115075981
Publisher: CIG Media Group, LP.
Year: 2009
Tongue: English
Weight: 130 KB
Volume: 7
Category: Article
ISSN: 1558-7673
DOI: 10.3816/cgc.2009.n.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase 1 trial of everolimus plus sunitin

Phase 1 trial of everolimus plus sunitinib in patients with metastatic renal cell carcinoma

✍ Ana M. Molina; Darren R. Feldman; Martin H. Voss; Michelle S. Ginsberg; Michael 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 817 KB

Phase 1 dose-escalation trial of tremeli

Phase 1 dose-escalation trial of tremelimumab plus sunitinib in patients with metastatic renal cell carcinoma

✍ Brian I. Rini; Mark Stein; Pat Shannon; Simantini Eddy; Allison Tyler; Joe J. St 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 273 KB 👁 2 views

Phase III Study of Sunitinib Malate (SU1

Phase III Study of Sunitinib Malate (SU11248) Versus Interferon-α as First-Line Treatment in Patients with Metastatic Renal Cell Carcinoma

✍ Kesava Reddy; Ronald M. Bukowski 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 110 KB

A phase I clinical trial of low-dose int

A phase I clinical trial of low-dose interferon-α-2A, thalidomide plus gemcitabine and capecitabine for patients with progressive metastatic renal cell carcinoma

✍ Robert J. Amato; Muhammad Khan 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 221 KB

797 ORAL Sunitinib malate (SU11248) show

797 ORAL Sunitinib malate (SU11248) shows antitumour activity in patients with metastatic renal cell carcinoma: updated results from phase II trials

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Phase II trial of 5-fluorouracil, interf

Phase II trial of 5-fluorouracil, interferon-α and continuous infusion interleukin-2 for patients with metastatic renal cell carcinoma

✍ Julie A. Ellerhorst; Avishay Sella; Robert J. Amato; Shi-Ming Tu; Randall E. Mil 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

## RESULTS. Fifty-five patients were enrolled in the trial and 52 were evaluable for ogy, The University of Texas M. D. Anderson response. All patients experienced fever and flu-like symptoms. Grade 3 or 4 nonhe-Cancer Center, Houston, Texas. matologic toxic effects included hypertension (48%), d